Novartis expands cardiovascular pipeline with $1.8bn macrocycle agreement with Unnatural Products
The collaboration pairs UNP’s AI-enhanced discovery platform, with the company focusing on early research activities, and Novartis’ global…
Unnatural Products, Novartis sign licensing agreement for cardiovascular program
Wed, February 18, 2026 at 1:35 PM UTC A sign marks the Novartis Institutes for BioMedical Research facility…